NCT03580122View on ClinicalTrials.gov

The Effect of Arginine on Classic Galactosemia

PHASE2CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

December 5, 2017

Primary Completion Date

January 12, 2018

Study Completion Date

September 5, 2018

Conditions
Classic Galactosemia
Interventions
DRUG

Arginine Aspartate

Asparten

Trial Locations (1)

6202 AZ

Academisch Ziekenhuis Maastricht, Maastricht

All Listed Sponsors
lead

Academisch Ziekenhuis Maastricht

OTHER

NCT03580122 - The Effect of Arginine on Classic Galactosemia | Biotech Hunter | Biotech Hunter